Chemoinformaics analysis of trans-4-Hydroxymethyl-D-proline
| Molecular Weight | 770.086 | nRot | 40 |
| Heavy Atom Molecular Weight | 689.446 | nRig | 1 |
| Exact Molecular Weight | 769.562 | nRing | 0 |
| Solubility: LogS | -0.342 | nHRing | 0 |
| Solubility: LogP | 0.624 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 133 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 53 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 80 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 43 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 136.299 |
| nHD | 1 | BPOL | 97.3726 |
| QED | 0.55 |
| Synth | 2.89 |
| Natural Product Likeliness | 1.149 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.007 |
| CACO-2 | -4.408 |
| MDCK | 0.0000368 |
| BBB | 0.989 |
| PPB | 0.0899155 |
| VDSS | 0.833 |
| FU | 0.759577 |
| CYP1A2-inh | 0.036 |
| CYP1A2-sub | 0.828 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.855 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.162 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.265 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.311 |
| CL | 7.506 |
| T12 | 0.814 |
| hERG | 0.03 |
| Ames | 0.03 |
| ROA | 0.018 |
| SkinSen | 0.086 |
| Carcinogencity | 0.037 |
| EI | 0.927 |
| Respiratory | 0.018 |
| NR-Aromatase | 0.18 |
| Antiviral | Yes |
| Prediction | 0.733394 |